Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Oct 18:21:84.
doi: 10.4103/1735-1995.192500. eCollection 2016.

Updates in diagnosis and management of Ebola hemorrhagic fever

Affiliations
Review

Updates in diagnosis and management of Ebola hemorrhagic fever

Salah Mohamed El Sayed et al. J Res Med Sci. .

Abstract

Ebola hemorrhagic fever is a lethal viral disease transmitted by contact with infected people and animals. Ebola infection represents a worldwide health threat causing enormous mortality rates and fatal epidemics. Major concern is pilgrimage seasons with possible transmission to Middle East populations. In this review, we aim to shed light on Ebola hemorrhagic fever as regard: virology, transmission, biology, pathogenesis, clinical picture, and complications to get the best results for prevention and management. We also aim to guide future research to new therapeutic perspectives to precise targets. Our methodology was to review the literature extensively to make an overall view of the biology of Ebola virus infection, its serious health effects and possible therapeutic benefits using currently available remedies and future perspectives. Key findings in Ebola patients are fever, hepatic impairment, hepatocellular necrosis, lymphopenia (for T-lymphocyte and natural killer cells) with lymphocyte apoptosis, hemorrhagic manifestations, and complications. Pathogenesis in Ebola infection includes oxidative stress, immune suppression of both cell-mediated and humoral immunities, hepatic and adrenal impairment and failure, hemorrhagic fever, activation of deleterious inflammatory pathways, for example, tumor necrosis factor-related apoptosis-inducing ligand, and factor of apoptotic signal death receptor pathways causing lymphocyte depletion. Several inflammatory mediators and cytokines are involved in pathogenesis, for example, interleukin-2, 6, 8, and 10 and others. In conclusion, Ebola hemorrhagic fever is a serious fatal viral infection that can be prevented using strict health measures and can be treated to some extent using some currently available remedies. Newer treatment lines, for example, prophetic medicine remedies as nigella sativa may be promising.

Keywords: Ebola hemorrhagic fever; filoviruses; fruit bats; pathogenesis; reverse transcription-polymerase chain reaction.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Ebola virus belongs to filoviruses. Filoviruses are large viruses that may reach 1400 nm in diameter
Figure 2
Figure 2
Structure of Ebola virus virion
Figure 3
Figure 3
Mode of transmission of Ebola virus infection: Transmission of Ebola virus occurs when man consumes the flesh of fruit bats, flesh of animals fed on infected fruit bats, or through contacting or touching any contaminated matter with the virus
Figure 4
Figure 4
Pathogenesis of Ebola hemorrhagic fever

Similar articles

Cited by

References

    1. Hartman AL, Bird BH, Towner JS, Antoniadou ZA, Zaki SR, Nichol ST. Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of Ebola virus. J Virol. 2008;82:2699–704. - PMC - PubMed
    1. Wauquier N, Becquart P, Padilla C, Baize S, Leroy EM. Human fatal zaire Ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop Dis. 2010;4:E837. - PMC - PubMed
    1. Choi WY, Hong KJ, Hong JE, Lee WJ. Progress of vaccine and drug development for Ebola preparedness. Clin Exp Vaccine Res. 2015;4:11–6. - PMC - PubMed
    1. WHO Ebola Response Team. Ebola virus disease in West Africa – The first 9 months of the epidemic and forward projections. N Engl J Med. 2014;371:1481–95. - PMC - PubMed
    1. Chippaux JP. Outbreaks of Ebola virus disease in Africa: The beginnings of a tragic saga. J Venom Anim Toxins Incl Trop Dis. 2014;20:44. - PMC - PubMed

LinkOut - more resources